Standout Papers

The american rheumatism association 1987 revised criteria for the classification of rheumatoi... 1988 2026 2000 2013 16.7k
  1. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis (1988)
    Frank C. Arnett, Steven M. Edworthy et al. Arthritis & Rheumatism
  2. The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment (2005)
    Ferdinand C. Breedveld, Michael H. Weisman et al. Arthritis & Rheumatism
  3. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial (2004)
    Edward Keystone, Arthur F. Kavanaugh et al. Arthritis & Rheumatism
  4. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial (2005)
    Philip J. Mease, Dafna D. Gladman et al. Arthritis & Rheumatism
  5. Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression (2004)
    Philip J. Mease, Alan Kivitz et al. Arthritis & Rheumatism
  6. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities (1971)
    John T. Sharp, Martin D. Lidsky et al. Arthritis & Rheumatism
  7. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen. (1960)
    Byron H. Waksman, Carl M. Pearson et al. PubMed

Immediate Impact

5 by Nobel laureates 6 from Science/Nature 243 standout
Sub-graph 1 of 11

Citing Papers

Rheumatoid arthritis
2023 Standout
Novel treatment strategies in rheumatoid arthritis
2017 Standout
375 intermediate papers

Works of John T. Sharp being referenced

Equivalent Responses to Disease-modifying Antirheumatic Drugs Initiated at Any Time During the First 15 Months After Symptom Onset in Patients with Seropositive Rheumatoid Arthritis
2010
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
2005 Standout
and 37 more

Author Peers

Author Last Decade Papers Cites
John T. Sharp 19976 2981 2757 6319 6098 212 30.1k
Frank C. Arnett 23969 2768 2685 5579 9154 196 37.1k
Matthew H. Liang 19455 1576 6787 4869 5308 192 36.6k
Ben A. C. Dijkmans 17930 976 1599 6033 6125 330 24.4k
Jane G. Schaller 23343 1712 1945 6122 10385 90 32.7k
Deborah Symmons 15633 1237 2582 4965 6721 390 26.4k
Ronald L. Wilder 13580 1209 1896 3693 5886 112 26.6k
Daniel E. Fürst 12018 1798 1733 5160 4535 252 21.5k
Pier Luigi Meroni 17592 2053 2633 7511 8822 607 28.0k
Sherine E. Gabriel 16015 3652 5202 3149 3944 199 28.4k
Michael H. Weisman 14535 1011 1472 4915 6012 338 21.6k

All Works

Loading papers...

Rankless by CCL
2026